| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |